{
  "company": {
    "name": "64x Bio",
    "website": "https://64xbio.com/",
    "record": "https://startuphistory.org/c/64xbio.com"
  },
  "status": null,
  "history_since": "2020-08-09T15:16:43.000Z",
  "baseline": {
    "snapshot_id": "8dc94247c1f9b65253eb74c97c3f22f38bed8abd126d63f2fc1ea3402f7334cd",
    "observed_at": "2020-08-09T15:16:43.000Z",
    "headline": "Genomes by design",
    "description": null,
    "evidence": "https://web.archive.org/web/20200809151643/https://www.64xbio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-04T09:36:57.492Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2020-08-09T15:16:43.000Z",
      "variants": [
        {
          "headline": "Genomes by design",
          "subhead": null,
          "observed_at": "2020-08-09T15:16:43.000Z",
          "evidence": "https://web.archive.org/web/20200809151643/https://www.64xbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Genomes by design",
      "subhead": null,
      "from": "2020-08-09T15:16:43.000Z",
      "to": "2020-08-09T15:16:43.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20200809151643/https://www.64xbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2020-08-09T15:16:43.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-01-02T08:57:29.000Z",
      "variants": [
        {
          "headline": "An evolution in cell line engineering.",
          "subhead": null,
          "observed_at": "2021-01-15T20:15:38.000Z",
          "evidence": "https://web.archive.org/web/20210115201538/https://www.64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "An evolution in cell line engineering.",
          "subhead": null,
          "observed_at": "2022-01-23T22:16:03.000Z",
          "evidence": "https://web.archive.org/web/20220123221603/https://www.64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "An evolution in cell line engineering.",
          "subhead": null,
          "observed_at": "2022-07-01T18:53:34.000Z",
          "evidence": "https://web.archive.org/web/20220701185334/https://www.64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "An evolution in cell line engineering.",
          "subhead": null,
          "observed_at": "2023-01-06T06:51:35.000Z",
          "evidence": "https://web.archive.org/web/20230106065135/https://www.64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "An evolution in cell line engineering.",
          "subhead": null,
          "observed_at": "2024-01-12T18:26:06.000Z",
          "evidence": "https://web.archive.org/web/20240112182606/https://www.64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "An evolution in cell line engineering.",
          "subhead": null,
          "observed_at": "2024-07-13T20:26:05.000Z",
          "evidence": "https://web.archive.org/web/20240713202605/https://www.64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "An evolution in cell line engineering.",
          "subhead": null,
          "observed_at": "2025-01-02T08:57:29.000Z",
          "evidence": "https://web.archive.org/web/20250102085729/https://www.64xbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "An evolution in cell line engineering.",
      "subhead": null,
      "from": "2021-01-15T20:15:38.000Z",
      "to": "2025-01-02T08:57:29.000Z",
      "captures": 7,
      "evidence": "https://web.archive.org/web/20250102085729/https://www.64xbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-01-15T20:15:38.000Z",
          "to": "2025-01-02T08:57:29.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-04T09:36:57.492Z",
      "variants": [
        {
          "headline": "Enabling next generation medicines",
          "subhead": "Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufac",
          "observed_at": "2025-07-20T15:59:32.000Z",
          "evidence": "https://web.archive.org/web/20250720155932/https://64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Enabling next generation medicines",
          "subhead": "Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufac",
          "observed_at": "2026-01-07T10:17:50.000Z",
          "evidence": "https://web.archive.org/web/20260107101750/https://64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Enabling next generation medicines",
          "subhead": "Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufac",
          "observed_at": "2026-01-14T01:10:23.000Z",
          "evidence": "https://web.archive.org/web/20260114011023/https://64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Enabling next generation medicines",
          "subhead": "Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufac",
          "observed_at": "2026-07-22T07:11:07.000Z",
          "evidence": "https://web.archive.org/web/20260722071107/https://64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Enabling next generation medicines",
          "subhead": "Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufac",
          "observed_at": "2026-07-22T07:11:36.000Z",
          "evidence": "https://web.archive.org/web/20260722071136/https://64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Enabling next generation medicines",
          "subhead": "Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufac",
          "observed_at": "2026-10-04T15:29:36.000Z",
          "evidence": "https://web.archive.org/web/20261004152936/https://64xbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Enabling next generation medicines",
          "subhead": "Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufac",
          "observed_at": "2026-11-04T09:36:57.492Z",
          "evidence": "https://64xbio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Enabling next generation medicines",
      "subhead": "Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufac",
      "from": "2025-07-20T15:59:32.000Z",
      "to": "2026-11-04T09:36:57.492Z",
      "captures": 7,
      "evidence": "https://64xbio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2025-07-20T15:59:32.000Z",
          "to": "2026-11-04T09:36:57.492Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-8dc94247c1f9b65253eb74c97c3f22f38bed8abd126d63f2fc1ea3402f7334cd:17abebcaf89cd1d70b0fceba62c04058393cfce45dc698739dc164b1159cc462:headline:dfd3ddfc0d9271d5",
      "before_evidence": "https://web.archive.org/web/20200809151643/https://www.64xbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Genomes by design” to “An evolution in cell line engineering.”.",
      "between": {
        "from": "2020-08-09T15:16:43.000Z",
        "to": "2021-01-15T20:15:38.000Z"
      },
      "evidence": "https://web.archive.org/web/20210115201538/https://www.64xbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-8dc94247c1f9b65253eb74c97c3f22f38bed8abd126d63f2fc1ea3402f7334cd:17abebcaf89cd1d70b0fceba62c04058393cfce45dc698739dc164b1159cc462:investors:c9b84bdb876bdc6a",
      "before_evidence": "https://web.archive.org/web/20200809151643/https://www.64xbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: SVA.png, Refactor.png, YC.png, FR.png, L2.png and 50Y.png.",
      "between": {
        "from": "2020-08-09T15:16:43.000Z",
        "to": "2021-01-15T20:15:38.000Z"
      },
      "evidence": "https://web.archive.org/web/20210115201538/https://www.64xbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    },
    {
      "n": 3,
      "id": "page-17abebcaf89cd1d70b0fceba62c04058393cfce45dc698739dc164b1159cc462:d38cde0f37b4416d2aff7500ca61e257672fd91399d7a7d10d7dcc15ce4139dd:investors:263ddf60e7f4d545",
      "before_evidence": "https://web.archive.org/web/20210115201538/https://www.64xbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: FR_edited.png, NV.png, LFC.png, FV.png and RC.png.",
      "between": {
        "from": "2021-01-15T20:15:38.000Z",
        "to": "2022-01-23T22:16:03.000Z"
      },
      "evidence": "https://web.archive.org/web/20220123221603/https://www.64xbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    },
    {
      "n": 4,
      "id": "page-8993c77c5aa41a5d41e9177ffd74302510a64386df0e2e6f6a95afbe865aefc3:454a779c4ad4e07547e06e7c3a5666404c725c004e0dd74e6f21b6eb2b734d06:headline:4967b92566222a28",
      "before_evidence": "https://web.archive.org/web/20250102085729/https://www.64xbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “An evolution in cell line engineering.” to “Enabling next generation medicines”.",
      "between": {
        "from": "2025-01-02T08:57:29.000Z",
        "to": "2025-07-20T15:59:32.000Z"
      },
      "evidence": "https://web.archive.org/web/20250720155932/https://64xbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “64x Bio” company record, https://startuphistory.org/c/64xbio.com"
}